Early left ventricular abnormality/dysfunction in obese children affected by NAFLD

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 1, 2014, Pages 72-74

  Fintini, D ^a   Chinali, M ^a   Cafiero, G ^a   Esposito, C ^a   Giordano, U ^a   Turchetta, A ^a   Pescosolido, S ^b   Pongiglione, G ^a   Nobili, V ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b ASL Roma D   (Italy)

Author keywords

Cardiovascular alteration; NAFLD; Obesity

Indexed keywords

ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MONITORING; CHILD; CLINICAL ARTICLE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LIVER BIOPSY; LIVER HISTOLOGY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; SCHOOL CHILD;

CARDIOVASCULAR ALTERATION; NAFLD; OBESITY;

ADOLESCENT; BLOOD PRESSURE; BODY MASS INDEX; CHILD; ECHOCARDIOGRAPHY, DOPPLER; FATTY LIVER; FEMALE; HEART; HUMANS; LIVER; MALE; PEDIATRIC OBESITY; PREVALENCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84894254732     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.06.005     Document Type: Article

References (8)

1. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010, 363:1341-1350.
2. Rijzewijk L.J., Jonker J.T., van der Meer R.W., Lubberink M., deJong H.W., Romijn J.A., et al. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. J Am Coll Cardiol 2010, 56:225-233.
3. Mofrad P., Contos M.J., Haque M., Sargeant C., Fisher R.A., Luketic V.A., et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003, 37(6):1286-1292.
4. Ricci C., Longo R., Gioulis E., Bosco M., Pollesello P., Masutti F., et al. Noninvasive invivo quantitative assessment of fat content in human liver. J Hepatol 1997, 27(1):108-113.
5. de Simone G., Kizer J.R., Chinali M., Roman M.J., Bella J.N., Best L.G., et al. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens 2005, 1:191-196. Strong Heart Study Investigators.
6. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41(6):1313-1321. Nonalcoholic Steatohepatitis Clinical Research Network.
7. Manco M., Bedogni G., Monti L., Morino G., Natali G., Nobili V. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis 2010, 209(2):463-468.
8. Pacifico L., Anania C., Martino F., Cantisani V., Pascone R., Marcantonio A., et al. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. Hepatology 2010, 52(5):1643-1651.